Learn about the latest advances in leveraging bespoke ctDNA testing in clinical trials.
| This week's Fierce Drug Delivery is brought to you by Natera Oncology.
Trouble viewing? Click here.
|
| | Thursday, October 14, 2021 | 11am ET / 8am PT | |
|
|
| | | Learn about the latest advances in leveraging bespoke ctDNA testing in clinical trials. Webinar topics will include: Latest clinical data from 2021 publications and presentations Advantages of a personalized, tumor-informed ctDNA assay for molecular residual disease detection Applications of Signatera in clinical trial design to maximize trial success and accelerate time to data readout |
|---|
| |
|
|
| | | | You are currently subscribed as [email protected]
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.
Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2021 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. | |
|
|
|
